Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Gen Physiol Biophys ; 10(2): 125-35, 1991 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-1713871

RESUMO

Monolayer cultures of human embryonal smooth muscle cells (HEC) were used to study the heterologous regulation of membrane beta-adrenergic receptors and Ca2+ channels. The relationships between the activation of membrane bound alpha-1 and beta-adrenergic receptors, the cyclic nucleotide response and Ca2+ channel binding were studied in a cellular model of latent virus infection (Herpes simplex, Type-2) in a human embryonal cell line. In the early stage of infection (72 h), there was a significant increase in the cell cAMP content, followed by a decrease in the binding capacity of the beta-adrenergic ligand with an increased total number of the 1,4-dihydropyridine Ca2+ channel agonist (-)-S-(3H)BAYK 8644 binding sites on the cell membrane of infected cells. The increased numbers of Ca2+ agonist binding sites were accompanied by an increased cAMP content in the cells and an increased membrane ATP-ase activity. Down-regulation of (3H)DHA binding, and an increased capacity of Ca2+ agonist binding were found after prolonged exposure of HEC to isoprenaline (10(-5) mol.l-1). Stimulation of alpha-1 adrenergic receptors with phenylephrine (10(-6) mol.l-1) was accompanied with only slight but significant increase in (3H)DHA binding and with a significant reduction in the total number of Ca2+ channel agonist binding sites.


Assuntos
Canais de Cálcio/metabolismo , Transformação Celular Viral , Receptores Adrenérgicos beta/metabolismo , Éster Metílico do Ácido 3-Piridinacarboxílico, 1,4-Di-Hidro-2,6-Dimetil-5-Nitro-4-(2-(Trifluormetil)fenil)/metabolismo , Éster Metílico do Ácido 3-Piridinacarboxílico, 1,4-Di-Hidro-2,6-Dimetil-5-Nitro-4-(2-(Trifluormetil)fenil)/farmacologia , ATPase de Ca(2+) e Mg(2+)/metabolismo , Canais de Cálcio/efeitos dos fármacos , Linhagem Celular Transformada , AMP Cíclico/metabolismo , Di-Hidroalprenolol/metabolismo , Embrião de Mamíferos , Humanos , Isoproterenol/farmacologia , Músculo Liso , Fenilefrina/farmacologia , Radioimunoensaio , Receptores Adrenérgicos beta/efeitos dos fármacos , Simplexvirus/fisiologia , Trifluoperazina/farmacologia
2.
Biomed Biochim Acta ; 50(12): 1251-4, 1991.
Artigo em Inglês | MEDLINE | ID: mdl-1840475

RESUMO

Administration of stobadine, a cardioprotective substance in investigation prevents a decrease in the content of protein SH groups and glutathione in hearts of rats treated with high doses of isoproterenol (ISO) (30 mg/kg). Moreover, stobadine also attenuated the increase in the content of malondialdehyde and activities of catalase and glutathione reductase as well as a diminution in the GSH/GSSG ratio observed in heart mitochondria isolated from ISO-treated animals. Since stobadine may be considered as a scavenger of reactive oxygen species (ROS), the above effects of the latter substance support the assumption about a possible involvement of reactive oxygen species (ROS) in some processes initiated by administration of ISO in doses inducing cardiac hypertrophy. However our results also indicate that ROS-mediated processes are not necessarily involved in the mechanism of induction of cardiac hypertrophy itself.


Assuntos
Antiarrítmicos/farmacologia , Carbolinas/farmacologia , Cardiomegalia/fisiopatologia , Sequestradores de Radicais Livres , Coração/efeitos dos fármacos , Isoproterenol/toxicidade , Mitocôndrias Cardíacas/metabolismo , Miocárdio/metabolismo , Proteínas/metabolismo , Animais , Peso Corporal/efeitos dos fármacos , Cardiomegalia/induzido quimicamente , Cardiomegalia/metabolismo , Catalase/metabolismo , Glutationa/metabolismo , Glutationa Redutase/metabolismo , Malondialdeído/metabolismo , Mitocôndrias Cardíacas/efeitos dos fármacos , Mitocôndrias Cardíacas/enzimologia , Miocárdio/patologia , Tamanho do Órgão/efeitos dos fármacos , Ratos , Ratos Endogâmicos , Compostos de Sulfidrila/metabolismo
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa